GlycA, a novel pro-inflammatory glycoprotein biomarker predicts mortality: Results from The PREVEND study and meta-analysis

Eke Gruppen; Setor Kunutsor; Lyanne Kieneker; Bert van der Vegt; Margery Connelly; Hans Hillege; Stephan Bakker; Robin Dullaart

GlycA, a novel pro-inflammatory glycoprotein biomarker predicts mortality: Results from The PREVEND study and meta-analysis

Eke Gruppen
, Setor Kunutsor
, Lyanne Kieneker
, Bert van der Vegt
, Margery Connelly
, Hans Hillege
, Stephan Bakker
, Robin Dullaart

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	74-75
Number of pages	2
Journal	European Journal of Clinical Investigation
Volume	49
Publication status	Published - Apr-2019

Handle.net

Persistent link

Prevention of Renal and Vascular End-stage Disease (PREVEND)
Gansevoort, R. T. (Creator), University of Groningen, 2017
https://www.umcg.nl/EN/Research/Researchers/Facilities/biobanks/biobanks/prevend/Paginas/default.aspx#
Dataset

Cite this

@article{36131c3c5634499d9e003ac837b453fa,

title = "GlycA, a novel pro-inflammatory glycoprotein biomarker predicts mortality: Results from The PREVEND study and meta-analysis",

author = "Eke Gruppen and Setor Kunutsor and Lyanne Kieneker and \{van der Vegt\}, Bert and Margery Connelly and Hans Hillege and Stephan Bakker and Robin Dullaart",

year = "2019",

month = apr,

language = "English",

volume = "49",

pages = "74--75",

journal = "European Journal of Clinical Investigation",

issn = "0014-2972",

publisher = "Wiley",

}

TY - JOUR

T1 - GlycA, a novel pro-inflammatory glycoprotein biomarker predicts mortality

T2 - Results from The PREVEND study and meta-analysis

AU - Gruppen, Eke

AU - Kunutsor, Setor

AU - Kieneker, Lyanne

AU - van der Vegt, Bert

AU - Connelly, Margery

AU - Hillege, Hans

AU - Bakker, Stephan

AU - Dullaart, Robin

PY - 2019/4

Y1 - 2019/4

M3 - Meeting Abstract

SN - 0014-2972

VL - 49

SP - 74

EP - 75

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

ER -

GlycA, a novel pro-inflammatory glycoprotein biomarker predicts mortality: Results from The PREVEND study and meta-analysis

Handle.net

Datasets

Prevention of Renal and Vascular End-stage Disease (PREVEND)

Cite this